We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USB icon
126
US Bancorp
USB
$101B
$13.2M 0.15%
358,494
-7,862
-2% -$280K
ITW icon
127
Illinois Tool Works
ITW
$83.6B
$13.1M 0.15%
75,191
-199
-0.3% -$32.5K
BSX icon
128
Boston Scientific
BSX
$75B
$13.1M 0.15%
373,656
+14,380
+4% +$518K
ICE icon
129
Intercontinental Exchange
ICE
$85.2B
$13.1M 0.15%
143,118
-417
-0.3% -$38.2K
NEM icon
130
Newmont
NEM
$124B
$13M 0.15%
209,905
-1,419
-0.7% -$84K
ECL icon
131
Ecolab
ECL
$78.5B
$12.9M 0.15%
64,677
+37
+0.1% +$7.16K
DE icon
132
Deere & Co
DE
$168B
$12.9M 0.15%
81,824
+662
+0.8% +$95.9K
WMB icon
133
Williams Companies
WMB
$90.1B
$12.8M 0.15%
672,013
+4,875
+0.7% +$90.7K
KMB icon
134
Kimberly-Clark
KMB
$36.3B
$12.6M 0.14%
89,065
+702
+0.8% +$96.9K
DG icon
135
Dollar General
DG
$26.5B
$12.5M 0.14%
65,835
+209
+0.3% +$37.8K
NOC icon
136
Northrop Grumman
NOC
$82.1B
$12.5M 0.14%
40,548
+147
+0.4% +$48.2K
ENB icon
137
Enbridge
ENB
$113B
$12.4M 0.14%
410,128
MPLX icon
138
MPLX
MPLX
$60.5B
$12.3M 0.14%
711,127
+10,330
+1% +$176K
LRCX icon
139
Lam Research
LRCX
$407B
$12.3M 0.14%
379,660
+5,700
+2% +$155K
PGR icon
140
Progressive
PGR
$121B
$12.3M 0.14%
153,076
+2,381
+2% +$186K
SHW icon
141
Sherwin-Williams
SHW
$87.8B
$12.2M 0.14%
63,408
-123
-0.2% -$22.2K
KMI icon
142
Kinder Morgan
KMI
$70.7B
$11.9M 0.14%
782,483
+68,570
+10% +$1.04M
COP icon
143
ConocoPhillips
COP
$153B
$11.8M 0.13%
280,479
-2,356
-0.8% -$95.3K
NSC icon
144
Norfolk Southern
NSC
$75.6B
$11.8M 0.13%
67,000
-211
-0.3% -$35.7K
ADI icon
145
Analog Devices
ADI
$187B
$11.7M 0.13%
95,548
+614
+0.6% +$67.4K
PNC icon
146
PNC Financial Services
PNC
$102B
$11.7M 0.13%
110,959
-1,985
-2% -$209K
AON icon
147
Aon
AON
$74.9B
$11.6M 0.13%
60,438
+86
+0.1% +$16K
MCO icon
148
Moody's
MCO
$83.1B
$11.6M 0.13%
42,173
+320
+0.8% +$81.3K
BIIB icon
149
Biogen
BIIB
$30.9B
$11.4M 0.13%
42,679
-3,833
-8% -$1.15M
BAX icon
150
Baxter International
BAX
$14.1B
$11.4M 0.13%
131,962
+360
+0.3% +$31.4K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.